Related Experiment Videos
Sprouty and cancer: the first terms report
Ting Ling Lo1, Chee Wai Fong, Permeen Yusoff
1Signal Transduction laboratory, Institute of Molecular and Cell Biology, 61 Biopolis Drive, #6-01, Proteos, Singapore, 138673.
Cancer Letters
|February 14, 2006
Summary
Sprouty genes, induced by the Ras/Erk pathway, inhibit this signaling. Deregulation of Sprouty expression in cancers suggests potential roles as tumor markers or suppressors in carcinogenesis.
Area of Science:
- Molecular biology
- Cell signaling
- Oncology
Background:
- The Ras/Erk pathway is crucial for multicellular organism development and mature cell signaling.
- Sprouty genes encode proteins that negatively regulate the upstream Ras/Erk pathway.
- Sprouty gene products are positioned to influence oncogene activity.
Purpose of the Study:
- To investigate the relevance of Sprouty gene expression levels in human carcinogenesis.
- To explore the potential of Sprouty genes as tumor markers or tumor suppressors.
Main Methods:
- Analysis of Sprouty gene expression in various human cancers.
- Review of existing data on Sprouty deregulation in cancer.
Main Results:
- Early data indicates deregulation of Sprouty expression in breast, prostate, and liver cancers.
- Some Sprouty genes show potential as biomarkers for cancer detection.
- Sprouty-derived proteins may function as tumor suppressors.
Conclusions:
- Sprouty gene expression is altered in several human cancers, highlighting their role in carcinogenesis.
- Sprouty genes and their protein products represent potential targets for cancer diagnostics and therapeutics.